Bioprocess Capital Ventures CE VF

About the Fund

Bioprocess Capital Ventures is a closed-end mutual fund of High-Risk (venture) investment. The fund was formed on December 19, 2007 engaging RVC and Vnesheconombank.

The investment activity of the fund is directed to stimulate the development of Biotechnology, Pharmacy, Fine Chemistry in Russia (in accordance with the priorities of the Russian Federation to transition the economy to one of innovative development).

Currently the fund's portfolio contains 6 companies from the Pharmacy and Biotechnology Areas, 2 companies from the Fine Chemistry Area and 1 Telecommunications Company. 6 of the fund's projects became Skolkovo's residents. Fund also had given grants for a total amount of nearly RUB 695 mln. (according to the data as of the end of the Third Quarter of 2014).

Basic parameters of the Fund

Target Size of the Fund: RUB 3,000 mln.
Period of functioning: 10 years, up till 2017
The fund carries out venture capital investment via purchase, ownership and sales of the securities (stock) of exclusively innovative companies having considerable growth potential
The venture Fund is managed by Bioprocess Capital Partners Management Company LLC (BCP MC) on the basis of Venture Fund Trust Management Rules (TMR).
The Investment Decisions in all cases are made under consensus, based on the results of independent scientific and technological audit and prospective appraisal of financial results.
The investment decisions are made by the Fund's Investment Committee.

Name	Bioprocess Capital Ventures
Form of Incorporation	Close-End Mutual Funds of High-Risk (Venture) Investments
Trust Management Rules	Registration No. 0945-94131984
End Date of Formation	December 19, 2007
VAV as of the end of formation	RUB 3,000,000,000
Number of issued shares	3,000 shares
Share Owners	RVC Vnesheconombank SC Fund's Venture Specialists
Management Company	Bioprocess Capital Partners Management Company LLC

Investment Committee

The Investment Committee was formed by MC and consists of the representatives of each limited liability partner. Each of them is entitled to participate in the fund's management, act on behalf of the fund or vote on the issues pertaining to the fund, except the representatives of RVC, having a consultative vote.